sur AFYREN (EPA:ALAFY)
AFYREN Reports 2024 Financial Results with Stable Outlook
AFYREN has released its audited financial results for 2024, noting significant operational gains despite a net loss of €9.75 million, slightly higher than in 2023. The company's focus on continuous production is supported by various non-dilutive financing channels, including a €10 million shareholder loan.
AFYREN NEOXY, the company's plant, produced and sold several dozen tons of biobased acids, gaining validation from key global markets. The team is preparing for continuous production in 2025, which is expected to achieve EBITDA breakeven after stabilization.
A stronger CSR performance bolstered business credibility, earning a silver ECOVADIS rating. The company aims to expand operations in France and Asia, with plans for three production units by 2028.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AFYREN